Indeed, brain deterioration after stroke is associated with elevated levels of glutamate—the major excitatory neurotransmitter in the mammalian central nervous system (CNS)—in the plasma and cerebral spinal fluid. One possible explanation for this glutamate build-up, reported by Mallolas and colleagues on page 711, is a mutation in the gene encoding the glutamate transporter protein EAAT2.
This mutation—a single adenine (A) to cytosine (C) change in the EAAT2 promoter—was equally prevalent in healthy individuals and stroke patients....
The Rockefeller University Press
2006
The Rockefeller University Press
2006
You do not currently have access to this content.